Duquesne Family Office »

Cogent Biosciences shares owned by Duquesne Family Office

Quarter-by-quarter ownership of Cogent Biosciences (COGT) shares owned by Duquesne Family Office from 13F filings

Historical chart of Duquesne Family Office investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by Duquesne Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by Duquesne Family Office

Quarter filed Position value Share count Share price at filing
2025-09-30 $15M 1.1M 14.36

More positions owned by Duquesne Family Office

Natera (NTRA)
Insmed Com Par $.01 (INSM)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Woodward Governor Company (WWD)
Coupang Cl A (CPNG)
MercadoLibre (MELI)
Docusign (DOCU)
Verona Pharma Sponsored Ads (VRNA)
Ishares Tr Msci Emg Mkt Etf (EEM)
Amazon (AMZN)
Roku Com Cl A (ROKU)
Figure Technology Solutio Com Cl A
Restaurant Brands Intl Inc Com equity / large cap (QSR)
Stubhub Hldgs Cl A

View all positions for Duquesne Family Office

Top funds holding Cogent Biosciences

FMR
BlackRock
Deerfield Management Company
Fairmount Funds Management
Kynam Capital Management
Vanguard Group
Commodore Capital
TCG Crossover Management
State Street Corporation
VR Adviser
Rtw Investments
Geode Capital Management
Henderson Group
Paradigm Biocapital Advisors
Octagon Capital Advisors

View all funds holding Cogent Biosciences